Indication

Inherited Retinal Dystrophy Associated With RPE65 Mutations

1 clinical trial

1 product

Clinical trial

A Multi-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of rAAV2-RPE65 Gene Therapy (LX101) in Subjects With Biallelic RPE65 Mutation-associated Inherited Retinal Dystrophy

Status: Active (not recruiting), Estimated PCD: 2023-12-06

Product